Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration.

Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, Hautmann MG, Brunner T, Tamaskovics B, Hinke A, Frey B, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Gostian AO, Fietkau R (2021)


Publication Language: English

Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Series: Journal of Clinical Oncology

City/Town: PHILADELPHIA

Book Volume: 39 (15_suppl)

Event location: online US

DOI: 10.1200/JCO.2021.39.15_suppl.6007

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hecht, M., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Klautke, G.,... Fietkau, R. (2021). Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. In Proceedings of the ASCO 2021 Annual Meeting. online, US: PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

MLA:

Hecht, Markus, et al. "Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration." Proceedings of the ASCO 2021 Annual Meeting, online PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2021.

BibTeX: Download